Last reviewed · How we verify
Reactive Focal Drug Administration
Reactive focal drug administration is a treatment approach that targets specific areas of the body with a drug.
Reactive focal drug administration is a treatment approach that targets specific areas of the body with a drug. Used for Treatment of various cancers.
At a glance
| Generic name | Reactive Focal Drug Administration |
|---|---|
| Sponsor | PATH |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Mechanism of action
This method involves delivering a drug directly to the affected area, reducing systemic side effects and improving efficacy. The exact mechanism of action depends on the specific drug used, but it often involves the release of a therapeutic agent at the site of disease.
Approved indications
- Treatment of various cancers
Common side effects
- Local irritation
Key clinical trials
- IPrEP Men's Study: Expanding the Reach of Prevention for Men in Kisumu, Kenya (EARLY_PHASE1)
- EFFECT OF PLAZEPOD VERSUS ELECTRICAL STIMULATION ON RISK OF FALLING IN HEMODIALYSIS PATIENTS (NA)
- Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand (NA)
- Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland (PHASE3)
- Malaria Elimination Pilot Study in Military Forces in Cambodia (PHASE4)
- Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration (PHASE4)
- Malaria High-Risk Populations in Namibia (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reactive Focal Drug Administration CI brief — competitive landscape report
- Reactive Focal Drug Administration updates RSS · CI watch RSS
- PATH portfolio CI